These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 17113036)
1. PRIMA-1 induces apoptosis by inhibiting JNK signaling but promoting the activation of Bax. Wang T; Lee K; Rehman A; Daoud SS Biochem Biophys Res Commun; 2007 Jan; 352(1):203-12. PubMed ID: 17113036 [TBL] [Abstract][Full Text] [Related]
2. Selective induction of apoptosis in mutant p53 premalignant and malignant cancer cells by PRIMA-1 through the c-Jun-NH2-kinase pathway. Li Y; Mao Y; Brandt-Rauf PW; Williams AC; Fine RL Mol Cancer Ther; 2005 Jun; 4(6):901-9. PubMed ID: 15956247 [TBL] [Abstract][Full Text] [Related]
3. PRIMA-1 selectively induces global DNA demethylation in p53 mutant-type thyroid cancer cells. Qiang W; Jin T; Yang Q; Liu W; Liu S; Ji M; He N; Chen C; Shi B; Hou P J Biomed Nanotechnol; 2014 Jul; 10(7):1249-58. PubMed ID: 24804545 [TBL] [Abstract][Full Text] [Related]
4. PRIMA-1 inhibits growth of breast cancer cells by re-activating mutant p53 protein. Liang Y; Besch-Williford C; Hyder SM Int J Oncol; 2009 Nov; 35(5):1015-23. PubMed ID: 19787255 [TBL] [Abstract][Full Text] [Related]
5. PRIMA-1, a mutant p53 reactivator, induces apoptosis and enhances chemotherapeutic cytotoxicity in pancreatic cancer cell lines. Izetti P; Hautefeuille A; Abujamra AL; de Farias CB; Giacomazzi J; Alemar B; Lenz G; Roesler R; Schwartsmann G; Osvaldt AB; Hainaut P; Ashton-Prolla P Invest New Drugs; 2014 Oct; 32(5):783-94. PubMed ID: 24838627 [TBL] [Abstract][Full Text] [Related]
6. PRIMA-1 induces caspase-mediated apoptosis in acute promyelocytic leukemia NB4 cells by inhibition of nuclear factor-κB and downregulation of Bcl-2, XIAP, and c-Myc. Farhadi E; Safa M; Sharifi AM; Bashash D Anticancer Drugs; 2017 Jan; 28(1):51-58. PubMed ID: 27548348 [TBL] [Abstract][Full Text] [Related]
7. Regression of progestin-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors in Sprague-Dawley rats by p53 reactivation and induction of massive apoptosis: a pilot study. Benakanakere I; Besch-Williford C; Ellersieck MR; Hyder SM Endocr Relat Cancer; 2009 Mar; 16(1):85-98. PubMed ID: 19075036 [TBL] [Abstract][Full Text] [Related]
8. Proteomic identification of heat shock protein 90 as a candidate target for p53 mutation reactivation by PRIMA-1 in breast cancer cells. Rehman A; Chahal MS; Tang X; Bruce JE; Pommier Y; Daoud SS Breast Cancer Res; 2005; 7(5):R765-74. PubMed ID: 16168122 [TBL] [Abstract][Full Text] [Related]
9. PRIMA-1 induces p53-mediated apoptosis by upregulating Noxa in esophageal squamous cell carcinoma with TP53 missense mutation. Furukawa H; Makino T; Yamasaki M; Tanaka K; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y Cancer Sci; 2018 Feb; 109(2):412-421. PubMed ID: 29168598 [TBL] [Abstract][Full Text] [Related]
10. Expression proteomics to p53 mutation reactivation with PRIMA-1 in breast cancer cells. Lee K; Wang T; Paszczynski AJ; Daoud SS Biochem Biophys Res Commun; 2006 Oct; 349(3):1117-24. PubMed ID: 16970918 [TBL] [Abstract][Full Text] [Related]
11. PRIMA-1(MET) induces nucleolar accumulation of mutant p53 and PML nuclear body-associated proteins. Rökaeus N; Klein G; Wiman KG; Szekely L; Mattsson K Oncogene; 2007 Feb; 26(7):982-92. PubMed ID: 16909106 [TBL] [Abstract][Full Text] [Related]
12. PRIMA-1 cytotoxicity correlates with nucleolar localization and degradation of mutant p53 in breast cancer cells. Russo D; Ottaggio L; Penna I; Foggetti G; Fronza G; Inga A; Menichini P Biochem Biophys Res Commun; 2010 Nov; 402(2):345-50. PubMed ID: 20946886 [TBL] [Abstract][Full Text] [Related]
13. PRIMA-1 induces apoptosis in acute myeloid leukaemia cells with p53 gene deletion. Nahi H; Merup M; Lehmann S; Bengtzen S; Möllgård L; Selivanova G; Wiman KG; Paul C Br J Haematol; 2006 Jan; 132(2):230-6. PubMed ID: 16398657 [TBL] [Abstract][Full Text] [Related]
14. PRIMA-1 synergizes with adriamycin to induce cell death in non-small cell lung cancer cells. Magrini R; Russo D; Ottaggio L; Fronza G; Inga A; Menichini P J Cell Biochem; 2008 Aug; 104(6):2363-73. PubMed ID: 18442053 [TBL] [Abstract][Full Text] [Related]
15. Effects of PRIMA-1 on wild-type L1210 cells expressing mutant p53 and drug-resistant L1210 cells lacking expression of p53: necrosis vs. apoptosis. Cory AH; Chen J; Cory JG Anticancer Res; 2006; 26(2A):1289-95. PubMed ID: 16619536 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo cytotoxic effects of PRIMA-1 on hepatocellular carcinoma cells expressing mutant p53ser249. Shi H; Lambert JM; Hautefeuille A; Bykov VJ; Wiman KG; Hainaut P; Caron de Fromentel C Carcinogenesis; 2008 Jul; 29(7):1428-34. PubMed ID: 18048389 [TBL] [Abstract][Full Text] [Related]
17. Roles of TP53 in determining therapeutic sensitivity, growth, cellular senescence, invasion and metastasis. McCubrey JA; Lertpiriyapong K; Fitzgerald TL; Martelli AM; Cocco L; Rakus D; Gizak A; Libra M; Cervello M; Montalto G; Yang LV; Abrams SL; Steelman LS Adv Biol Regul; 2017 Jan; 63():32-48. PubMed ID: 27776972 [TBL] [Abstract][Full Text] [Related]
18. Activation of Jun N-terminal kinase is a mediator of vincristine-induced apoptosis of melanoma cells. Zhu BK; Wang P; Zhang XD; Jiang CC; Chen LH; Avery-Kiejda KA; Watts R; Hersey P Anticancer Drugs; 2008 Feb; 19(2):189-200. PubMed ID: 18176116 [TBL] [Abstract][Full Text] [Related]
19. Mutant and wild-type p53 form complexes with p73 upon phosphorylation by the kinase JNK. Wolf ER; McAtarsney CP; Bredhold KE; Kline AM; Mayo LD Sci Signal; 2018 Apr; 11(524):. PubMed ID: 29615516 [TBL] [Abstract][Full Text] [Related]
20. P53 activation plays a crucial role in silibinin induced ROS generation via PUMA and JNK. Fan S; Qi M; Yu Y; Li L; Yao G; Tashiro S; Onodera S; Ikejima T Free Radic Res; 2012 Mar; 46(3):310-9. PubMed ID: 22283740 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]